0000899243-22-018605.txt : 20220518 0000899243-22-018605.hdr.sgml : 20220518 20220518162239 ACCESSION NUMBER: 0000899243-22-018605 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220516 FILED AS OF DATE: 20220518 DATE AS OF CHANGE: 20220518 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sanna Bastiano CENTRAL INDEX KEY: 0001829069 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 22939383 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-05-16 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001829069 Sanna Bastiano C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 EVP, Cell & Genetic Therapies Common Stock 2022-05-16 4 S 0 7 250.56 D 41787 D Common Stock 2022-05-16 4 S 0 8 251.37 D 41779 D Common Stock 2022-05-16 4 S 0 7 252.43 D 41772 D Common Stock 2022-05-16 4 S 0 15 253.99 D 41757 D Common Stock 2022-05-16 4 S 0 8 254.44 D 41749 D Transaction made pursuant to Dr. Sanna's company approved trading plan under Rule 10b5-1. Dr. Sanna undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $250.56 (range $250.00 to $250.87). Open market sales reported on this line occurred at a weighted average price of $251.37 (range $251.00 to $251.88). Open market sales reported on this line occurred at a weighted average price of $252.43 (range $252.15 to $253.07). Open market sales reported on this line occurred at a weighted average price of $253.99 (range $253.33 to $254.32). Open market sales reported on this line occurred at a weighted average price of $254.44 (range $254.35 to $254.57). /s/ Sabrina Yohai, Attorney-in-Fact 2022-05-18